| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/31/2011 | US20110078821 Heat resistant plants and plant tissues and methods and materials for making and using same |
| 03/31/2011 | US20110078820 Methods and compositions for transgenic plants producing antimicrobial peptides for enhanced disease resistance |
| 03/31/2011 | US20110078819 Method and Appartus for Extraction of Plant Embryos |
| 03/31/2011 | US20110078818 Gene for increasing the production of plant biomass and/or seeds and method for use thereof |
| 03/31/2011 | US20110078813 Lettuce cultivar boulder |
| 03/31/2011 | US20110078812 Lettuce cultivar manitou |
| 03/31/2011 | US20110078810 Soybean cultivar s080137 |
| 03/31/2011 | US20110078809 Soybean cultivar s080100 |
| 03/31/2011 | US20110078808 Soybean cultivar s080099 |
| 03/31/2011 | US20110078807 Wheat Cultivar DA904-32W |
| 03/31/2011 | US20110078806 Polynucleotides and polypeptides in plants |
| 03/31/2011 | US20110078805 Compositions and methods for generating transgenic animals |
| 03/31/2011 | US20110077702 Means and Methods for Influencing Electrical Activity of Cells |
| 03/31/2011 | US20110077415 UV Excitable Fluorescent Energy Transfer Dyes |
| 03/31/2011 | US20110077288 Pharmaceutical Compositions for Treatment of MicroRNA Related Diseases |
| 03/31/2011 | US20110077287 Pharmaceutical composition containing a stabilised mrna optimised for translation in its coding regions |
| 03/31/2011 | US20110077286 Oligonucleotide duplexes comprising dna-like and rna-like nucleotides and uses thereof |
| 03/31/2011 | US20110077285 Rna antagonist compounds for the modulation of pik3ca expression |
| 03/31/2011 | US20110077223 Chimeric promoters for use in plants |
| 03/31/2011 | US20110077208 Expression of secreted human alpha-fetoprotein in transgenic animals |
| 03/31/2011 | US20110077203 Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use |
| 03/31/2011 | US20110077199 Growth hormone polypeptides and methods of making and using same |
| 03/31/2011 | US20110077197 Novel insulin derivatives having an extremely delayed time-action profile |
| 03/31/2011 | US20110077196 Non-standard insulin analogues |
| 03/31/2011 | US20110077173 siRNA targeting TIE-2 |
| 03/31/2011 | US20110076773 Delivery of DNA or RNA via gap junctions from host cells to target cells and a cell-based delivery system for antisense or siRNA |
| 03/31/2011 | US20110076763 Neoplasm specific antibodies and uses thereof |
| 03/31/2011 | US20110076761 Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers |
| 03/31/2011 | US20110076760 Viral expression plasmids for production of proteins, antibodies, enzymes, virus-like particles and for use in cell-based assays |
| 03/31/2011 | US20110076744 Compositions and methods to prevent AAV vector aggregation |
| 03/31/2011 | US20110076742 Polynucleotides encoding novel pcsk9 variants |
| 03/31/2011 | US20110076741 Alpha-amylase variants |
| 03/31/2011 | US20110076739 Catalytic domains from lysyl oxidase and loxl2 |
| 03/31/2011 | US20110076731 promoter, and a production method for l-lysine using the same |
| 03/31/2011 | US20110076730 Microbial synthesis of d-1,2,4-butanetriol |
| 03/31/2011 | US20110076723 Antibody-peptide fused synergibody |
| 03/31/2011 | US20110076722 Stable multivalent antibody |
| 03/31/2011 | US20110076707 Mutant glucose dehydrogenase |
| 03/31/2011 | US20110076699 Hemolysin and its protein fragments in sero-detection of anaplasma phagocytophilum |
| 03/31/2011 | US20110076696 Cardiovascular safety assay |
| 03/31/2011 | US20110076681 Modified gene-silencing nucleic acid molecules and uses thereof |
| 03/31/2011 | US20110076678 Reprogramming of somatic cells |
| 03/31/2011 | US20110076676 Method of Purifying RNA Binding Protein-RNA Complexes |
| 03/31/2011 | US20110076302 Plant-derived vaccines against respiratory syncytial virus |
| 03/31/2011 | US20110076300 Hybrid Polypeptides Including Meningococcal fHBP Sequences |
| 03/31/2011 | US20110076299 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 03/31/2011 | US20110076298 Soluble stabilized trimeric hiv env proteins and uses thereof |
| 03/31/2011 | US20110076296 TLR3 Agonist Compositions |
| 03/31/2011 | US20110076289 Transgenic animal model of neurodegenerative disorders |
| 03/31/2011 | US20110076286 Methods of inhibiting unwanted cell proliferation using hedgehog antagonists |
| 03/31/2011 | US20110076279 Fully human anti-vegf antibodies and methods of using |
| 03/31/2011 | US20110076268 Antibodies against human respiratory syncytial virus (RSV) and methods of use |
| 03/31/2011 | US20110076267 Humanized antibody compositions and methods for binding lysophosphatidic acid |
| 03/31/2011 | US20110076265 Monoclonal antibodies having homosubtype cross-neutralization properties against influenza a viruses subtype h1 |
| 03/31/2011 | US20110076262 Humanized anti-fgf19 antagonists and methods using same |
| 03/31/2011 | US20110076260 Proteases Producing an Altered Immunogenic Response and Methods of Making and Using the Same |
| 03/31/2011 | US20110076257 Modified Nucleotide Sequence Encoding Glucagon-Like Peptide-1 (GLP-1), Nucleic Acid Construct Comprising Same for Production of Glucagon-Like Peptide-1 (GLP-1), Human Cells Comprising Said Construct and Insulin-Producing Constructs, and Method of Use Thereof |
| 03/31/2011 | US20110076251 Novel therapeutic agents against hepatitis |
| 03/31/2011 | US20110076248 Immunizing compositions comprising hiv-1 proviral constructs with an inactive p6 gag tsg101 uev binding domain capable of producing budding-defective viral particles that remain tethered to the cell surface. |
| 03/31/2011 | DE112008003414T5 Lipidmetabolismus-Proteine, Kombinationen von Lipidmetabolismus-Proteinen und Anwendungen davon Lipid metabolism proteins, combinations of lipid metabolism proteins and uses thereof |
| 03/31/2011 | CA2807754A1 Method for transforming stramenopiles |
| 03/31/2011 | CA2775704A1 Cellulose and xylan fermentation by novel anaerobic thermophilic clostridia isolated from self-heated biocompost |
| 03/31/2011 | CA2775465A1 High-yield antibiotics producing fungus strain, preparation method and use thereof |
| 03/31/2011 | CA2775390A1 Method for producing 3-hydroxypropionic acid and other products |
| 03/31/2011 | CA2775151A1 Novel chimeric polynucleotides and polypeptides enabling the secretion of a polypeptide of interest in combination with exosomes and uses thereof |
| 03/31/2011 | CA2775111A1 Treatment of filaggrin (flg) related diseases by modulation of flg expression and activity |
| 03/31/2011 | CA2775092A1 Compositions and methods for silencing genes expressed in cancer |
| 03/31/2011 | CA2775045A1 Subtilase variants |
| 03/31/2011 | CA2774975A1 Production of fatty acid derivatives |
| 03/31/2011 | CA2773879A1 Plants having enhanced yield-related traits and a method for making the same |
| 03/31/2011 | CA2773240A1 Process for producing molecules containing specialized glycan structures |
| 03/31/2011 | CA2773186A1 Compositions, methods, and kits for isolating and analyzing nucleic acids using an anion exchange material |
| 03/31/2011 | CA2772983A1 Plants having enhanced yield-related traits and a method for making the same |
| 03/31/2011 | CA2772964A1 Method of preparing plant-derived proteins |
| 03/31/2011 | CA2772230A1 Humanized antibodies specific for amino acid sequence rgd of an extracellular matrix protein and the uses thereof |
| 03/30/2011 | EP2302391A1 Therapeutic and diagnostic uses of antibody specificity profiles in rheumatoid arthritis |
| 03/30/2011 | EP2302388A1 COP1 molecules and uses thereof |
| 03/30/2011 | EP2302387A1 Therapeutic and diagnostic uses of antibody specificity profiles for insulin-dependent diabetes mellitus |
| 03/30/2011 | EP2302077A1 PSMB9 is a marker of immunological tolerance and transplant rejection |
| 03/30/2011 | EP2302066A1 Method for producing aminohydroxybenzoic acid |
| 03/30/2011 | EP2302064A1 Method for producing biodegradable, functionalised polymer particles, and use of the same as medicament carriers |
| 03/30/2011 | EP2302063A2 Intact minicells as vectors for DNA transfer and gene therapy in vitro and in vivo |
| 03/30/2011 | EP2302062A1 Identification of E2F target genes and uses thereof |
| 03/30/2011 | EP2302061A1 Clubroot resistant brassica oleracea plants |
| 03/30/2011 | EP2302060A1 Enzymes |
| 03/30/2011 | EP2302059A1 Modifications of hiv Env, Gag, and Pol enhance immunogenicity for genetic immunization |
| 03/30/2011 | EP2302058A1 Corynebacterium glutamicum genes encoding proteins involved in homeostasis and adaptation |
| 03/30/2011 | EP2302057A1 Control of gene expression |
| 03/30/2011 | EP2302056A1 Methods and compositions involving miRNA and miRNA inhibitor molecules |
| 03/30/2011 | EP2302055A1 Methods and compositions involving miRNA and miRNA inhibitor molecules |
| 03/30/2011 | EP2302054A1 Methods and compositions involving miRNA and miRNA inhibitor molecules |
| 03/30/2011 | EP2302053A1 Methods and compositions involving miRNA and miRNA inhibitor molecules |
| 03/30/2011 | EP2302052A1 Methods and compositions involving miRNA and miRNA inhibitor molecules |
| 03/30/2011 | EP2302051A1 Methods and compositions involving miRNA and miRNA inhibitor molecules |
| 03/30/2011 | EP2302050A1 Method for evaluation of developmental toxicity |
| 03/30/2011 | EP2302048A1 Variants with altered properties |
| 03/30/2011 | EP2302047A1 Protein glycosylation modification in Pichia pastoris |
| 03/30/2011 | EP2302044A1 Lipolytic enzyme variants |
| 03/30/2011 | EP2302043A2 Lipolytic enzyme variants |
| 03/30/2011 | EP2302041A1 Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer |